ROLE OF PKC ISOFORMS AND PKD1 IN THE INHIBITION OF NF-κB ACTIVATION BY A VITAMIN K2 IN HUMAN HEPATOCELLULAR CARCINOMA CELLS

被引：0
|
作者：
Xia, He J. [1 ]
Ozaki, Iwata [1 ]
Matsuhashi, Sachiko [1 ]
Hamajima, Hiroshi [1 ]
Iwane, Shinji [1 ]
Takahashi, Hirokazu [1 ]
Eguchi, Yuichiro [1 ]
Mizuta, Toshihiko [1 ]
机构：
[1] Saga Med Sch, Hlth Adm Ctr, Saga, Japan
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：715A / 716A
页数：2
相关论文
共 50 条
  • [11] Vitamin K2 inhibits human hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of NF-KB activation
    Ide, Y
    Ozaki, I
    Zhang, H
    Mizuta, T
    Eguchi, Y
    Yasutake, T
    Hisatomi, A
    Yamamoto, K
    HEPATOLOGY, 2005, 42 (04) : 644A - 645A
  • [12] Role of Rel/NF-κB transcription factors in apoptosis of human hepatocellular carcinoma cells
    Chiao, PJ
    Na, R
    Niu, JG
    Sclabas, GM
    Dong, QG
    Curley, SA
    CANCER, 2002, 95 (08) : 1696 - 1705
  • [13] Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation
    Otsuka, M
    Kato, N
    Shao, RX
    Hoshida, Y
    Ijichi, H
    Koike, Y
    Taniguchi, H
    Moriyama, M
    Shiratori, Y
    Kawabe, T
    Omata, M
    HEPATOLOGY, 2004, 40 (01) : 243 - 251
  • [14] Potential role of vitamin K2 as a chemopreventive agent against hepatocellular carcinoma
    Tamori, Akihiro
    Habu, Daiki
    Shiomi, Susumu
    Kubo, Shoji
    Nishiguchi, Shuhei
    HEPATOLOGY RESEARCH, 2007, 37 : S303 - S307
  • [15] Involvement of NF-κB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells
    Wu, Ling-Fei
    Li, Guo-Ping
    Su, Jian-Dong
    Pu, Ze-Jin
    Feng, Jia-Lin
    Ye, Yan-Qing
    Wei, Bi-Liu
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2010, 88 (04): : 705 - 714
  • [16] Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K2
    Teruhisa Yamamoto
    Hideji Nakamura
    Weidong Liu
    Ke Cao
    Shohei Yoshikawa
    Hirayuki Enomoto
    Yoshinori Iwata
    Noritoshi Koh
    Masaki Saito
    Hiroyasu Imanishi
    Soji Shimomura
    Hiroko Iijima
    Toshikazu Hada
    Shuhei Nishiguchi
    Journal of Gastroenterology, 2009, 44 : 228 - 235
  • [17] Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K2
    Yamamoto, Teruhisa
    Nakamura, Hideji
    Liu, Weidong
    Cao, Ke
    Yoshikawa, Shohei
    Enomoto, Hirayuki
    Iwata, Yoshinori
    Koh, Noritoshi
    Saito, Masaki
    Imanishi, Hiroyasu
    Shimomura, Soji
    Iijima, Hiroko
    Hada, Toshikazu
    Nishiguchi, Shuhei
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (03) : 228 - 235
  • [18] INVOLVEMENT OF HEPATOMA-DERIVED GROWTH FACTOR IN THE GROWTH, INHIBITION OF HEPATOCELLULAR CARCINOMA CELLS BY VITAMIN K2
    Nakamura, Hideij
    Yamamoto, Teruhisa
    Liu, Weidong
    Enomoto, Hiroyuki
    Yoshikawa, Shohei
    Iwato, Yoshinori
    Koh, Noritoshi
    Saito, Mosoki
    Imanishi, Hiroyosu
    Shimomura, Soji
    Iijimo, Hirako
    Nishiguchi, Shuhei
    HEPATOLOGY, 2008, 48 (04) : 1119A - 1119A
  • [19] Regorafenib induces extrinsic and intrinsic apoptosis through inhibition of ERK/NF-κB activation in hepatocellular carcinoma cells
    Tsai, Jai-Jen
    Pan, Po-Jung
    Hsu, Fei-Ting
    ONCOLOGY REPORTS, 2017, 37 (02) : 1036 - 1044
  • [20] Inhibition of multiple matrix metalloproteinase expression by vitamin K2 through protein kinase C pathway in human hepatocellular carcinoma cells
    Idel, Y.
    Zhang, H.
    Mizuta, T.
    Eguchi, Y.
    Yasutake, T.
    Hisatomi, A.
    Ozakil, I.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S140 - S141
12345